Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

DDP Therapeutics

2005 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
2 FINANCING ROUNDS
Description

Manufacturer of drugs. The company develops early stage compounds used in the treatment of small cell lung cancer ("SCLC").

Formerly Known As
6441513 Canada
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Primary Office
  • 1547 Merivale Road
  • P.O. Box 5087
  • Ottawa, Ontario K2C 3H3
  • Canada

DDP Therapeutics Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore DDP Therapeutics‘s full profile, request access.

Request full access to PitchBook

DDP Therapeutics Executive Team (2)

Name Title Board
Seat
Contact
Info
J.L. Scott Baker Chief Executive Officer & President

1 Former Executive

You’re viewing 1 of 2 executives. Get the full list »